Autopsy report · NCT01131455
ACP for Local Application in Ankle Arthrodesis
Cause of deathSafety
“Study was terminated due to the untimely death of the investigator”
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 9 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 4 years 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Columbia Orthopaedic Group, LLP
- Sponsor type
- University, hospital or other
- Conditions
- Ankle Arthritis
- Interventions
- Autologous Concentrated Plasma
- Participants
- 10
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger
“Due to the investigator leaving the institution, the study was terminated” - Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
“Study was terminated due to safety reason.” - A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
“The study terminated for safety reasons” - A Study of Mitomycin C, Irinotecan, and Cetuximab
“The study was discontinued due to the death of a co-investigator and a second co-investigator leaving the institution.” - Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
“The study was terminated due to a business decision.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.